Innovate, Protect, Translate: IP Strategies That Power the RNA Therapeutics Development Pipeline

James Velema is a partner at Lathrop GPM and leads the firm’s biotech patent prosecution team. With a deep understanding of both biotechnology businesses and their technologies, James provides strategic counsel to clients ranging from startups to Fortune 500 companies. His practice focuses on patent preparation, prosecution, due diligence, and opinion work, with expertise in areas such as oligonucleotide therapeutics, gene therapy, biologic therapies, and vaccines.

A founding partner of the firm’s Boston office, James combines his extensive research experience in industry and academia with his entrepreneurial spirit to help clients build robust patent portfolios. Recognized as a “Go To Intellectual Property Lawyer” by Massachusetts Lawyers Weekly, James is known for his holistic approach to patent strategy, ensuring that every aspect of a client’s portfolio aligns with their business goals.